Related Experiment Video
Updated: May 19, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Visionary Leadership in Cancer Care: An Interview With Professor Timothy J. Eberlein
Ken Shirabe1, Koshi Mimori2, Masaki Mori3
1Department of General Surgical Science Graduate School of Medicine Maebashi Gunma Japan.
Abstract:
This is a short interview with Professor Timothy J. Eberlein, conducted by Professor Ken Shirabe, President of the Japanese Society of Gastroenterological Surgery, explores the vision, strategies, and leadership behind developing the Siteman Cancer Center into a world-class institution. Professor Eberlein emphasizes two central goals: becoming experts in every type of cancer and ensuring that every patient feels uniquely cared for. He highlights the importance of large-scale clinical programs in sustaining a virtuous cycle of academic medicine, where clinical revenue supports research and education, and innovations attract both patients and trainees. A distinctive element of his philosophy is individualized training, offering flexibility for surgical residents to focus on areas such as oncology, minimally invasive surgery, or education. He underscores the critical role of mentorship, collaboration, and laboratory organization in nurturing surgeon-scientists. Balancing surgery and research is described as a delicate challenge, but one that can be overcome with proper mentorship and collaboration. Leadership is about leading by example, solving problems for others, and respecting every member of the healthcare team. He stresses that surgery is the ultimate team sport, with outcomes dependent on the collective contributions of diverse professionals. Finally, his message to the next generation of surgeons and oncologists in Japan is to maintain their passion, embrace innovation, and realize that the future holds opportunities, such as genetic therapies, vaccines, and immune therapies that will revolutionize cancer treatment when combined with surgical expertise.
More Related Videos
08:26Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...